These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 16552076

  • 1. Active immunization against Pneumocystis carinii with a recombinant P. carinii antigen.
    Wells J, Haidaris CG, Wright TW, Gigliotti F.
    Infect Immun; 2006 Apr; 74(4):2446-8. PubMed ID: 16552076
    [Abstract] [Full Text] [Related]

  • 2. [Immunogenicity of p55 gene fragment from Pneumocystis carinii].
    Chen JL, Duan YN, Wang JX, Zhu DD, Qin YW.
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2009 Dec; 27(6):494-7. PubMed ID: 20232632
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Passive immunization of neonatal mice against Pneumocystis carinii f. sp. muris enhances control of infection without stimulating inflammation.
    Empey KM, Hollifield M, Schuer K, Gigliotti F, Garvy BA.
    Infect Immun; 2004 Nov; 72(11):6211-20. PubMed ID: 15501746
    [Abstract] [Full Text] [Related]

  • 7. Synthetic p55 tandem DNA vaccine against Pneumocystis carinii in rats.
    Fan H, Guo JY, Ma SL, Zhang N, An CL.
    Microbiol Immunol; 2016 Jun; 60(6):397-406. PubMed ID: 27185490
    [Abstract] [Full Text] [Related]

  • 8. Complement and Fc function are required for optimal antibody prophylaxis against Pneumocystis carinii pneumonia.
    Wells J, Haidaris CG, Wright TW, Gigliotti F.
    Infect Immun; 2006 Jan; 74(1):390-3. PubMed ID: 16368994
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Recognition of Pneumocystis carinii antigens by local antibody-secreting cells following resolution of P. carinii pneumonia in mice.
    Gigliotti F, Garvy BA, Haidaris CG, Harmsen AG.
    J Infect Dis; 1998 Jul; 178(1):235-42. PubMed ID: 9652446
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Discordant antibody and cellular responses to Pneumocystis major surface glycoprotein variants in mice.
    Bishop LR, Helman D, Kovacs JA.
    BMC Immunol; 2012 Jul 12; 13():39. PubMed ID: 22788748
    [Abstract] [Full Text] [Related]

  • 18. Active immunization against Pneumocystis carinii with p55-v3 DNA vaccine in rats.
    Feng Y, Guo S, Jiang T, Han X, Liu P, Wu T, Luo Y.
    Can J Microbiol; 2011 May 12; 57(5):375-81. PubMed ID: 21529125
    [Abstract] [Full Text] [Related]

  • 19. Antibody responses to a major Pneumocystis carinii antigen in human immunodeficiency virus-infected patients with and without P. carinii pneumonia.
    Lundgren B, Lundgren JD, Nielsen T, Mathiesen L, Nielsen JO, Kovacs JA.
    J Infect Dis; 1992 Jun 12; 165(6):1151-5. PubMed ID: 1583338
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.